Chronic phase chronic myelogenous leukemia

Results: 9



#Item
1correspondence Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up Despite their efficacy in inducing deep and

correspondence Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up Despite their efficacy in inducing deep and

Add to Reading List

Source URL: michorlab.dfci.harvard.edu

Language: English - Date: 2013-12-12 17:40:33
2Chronic myeloid leukaemia Initial PBS authority application Imatinib mesylate, accelerated or blast phase Supporting information When to use this form

Chronic myeloid leukaemia Initial PBS authority application Imatinib mesylate, accelerated or blast phase Supporting information When to use this form

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2014-09-09 22:04:37
3Chronic myeloid leukaemia, chronic phase First line initial PBS authority application Supporting information When to use this form

Chronic myeloid leukaemia, chronic phase First line initial PBS authority application Supporting information When to use this form

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English
4Should nilotinib replace imatinib as first line treatment of chronic myeloid leukemia in chronic phase (CML-CP)? http://test.metromomsblog.org/wp-content/uploads[removed]tortoise-and-the-hare.jpg

Should nilotinib replace imatinib as first line treatment of chronic myeloid leukemia in chronic phase (CML-CP)? http://test.metromomsblog.org/wp-content/uploads[removed]tortoise-and-the-hare.jpg

Add to Reading List

Source URL: www.utexas.edu

Language: English - Date: 2010-10-06 15:07:02
5Decision modelling using time on treatment data: evaluating the survival benefit of nilotinib versus imatinib in patients with chronic phase Ph+ CML

Decision modelling using time on treatment data: evaluating the survival benefit of nilotinib versus imatinib in patients with chronic phase Ph+ CML

Add to Reading List

Source URL: eprints.whiterose.ac.uk

Language: English - Date: 2014-06-04 14:54:10
6Authorization with conditions of prSPRYCEL* for the treatment of adults with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+CML) in chronic phase Fact Sheet What is SPRYCEL? SPRYCEL is a dr

Authorization with conditions of prSPRYCEL* for the treatment of adults with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+CML) in chronic phase Fact Sheet What is SPRYCEL? SPRYCEL is a dr

Add to Reading List

Source URL: www.bmscanada.ca

Language: English - Date: 2011-08-09 16:58:22
71999 Prostate Cancer Research Program Awards Book

1999 Prostate Cancer Research Program Awards Book

Add to Reading List

Source URL: cdmrp.army.mil

Language: English - Date: 2007-10-11 13:33:50
8Cancer Therapy: Clinical Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-SensitiveTyrosine Kinases Michael C. Heinrich,1 Heik

Cancer Therapy: Clinical Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-SensitiveTyrosine Kinases Michael C. Heinrich,1 Heik

Add to Reading List

Source URL: clincancerres.aacrjournals.org

Language: English
9Establishment of a novel CML model using Multi Hit technology: CMLMULTIHIT Tatsuaki Mizutani, Japan International Incoming Fellowship Ludwig-Boltzmann Institute for Cancer Research, Austria

Establishment of a novel CML model using Multi Hit technology: CMLMULTIHIT Tatsuaki Mizutani, Japan International Incoming Fellowship Ludwig-Boltzmann Institute for Cancer Research, Austria

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2012-05-30 09:15:10